Liraglutide for patients with non-alcoholic steatohepatitis - Authors' reply

Philip N Newsome; Matthew J Armstrong; Piers Gaunt

doi:10.1016/S0140-6736(16)30672-9

Liraglutide for patients with non-alcoholic steatohepatitis - Authors' reply

Philip N Newsome, Matthew J Armstrong, Piers Gaunt

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2379
Journal	The Lancet
Volume	387
Issue number	10036
Early online date	9 Jun 2016
DOIs	https://doi.org/10.1016/S0140-6736(16)30672-9
Publication status	Published - 11 Jun 2016

Keywords

Female
Humans
Incretins
Liraglutide
Male
Non-alcoholic Fatty Liver Disease

Access to Document

10.1016/S0140-6736(16)30672-9

Cite this

@article{967530e7e08d474c82037d787dfaf550,

title = "Liraglutide for patients with non-alcoholic steatohepatitis - Authors' reply",

keywords = "Female, Humans, Incretins, Liraglutide, Male, Non-alcoholic Fatty Liver Disease",

author = "Newsome, {Philip N} and Armstrong, {Matthew J} and Piers Gaunt",

year = "2016",

month = jun,

day = "11",

doi = "10.1016/S0140-6736(16)30672-9",

language = "English",

volume = "387",

pages = "2379",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "10036",

}

TY - JOUR

T1 - Liraglutide for patients with non-alcoholic steatohepatitis - Authors' reply

AU - Newsome, Philip N

AU - Armstrong, Matthew J

AU - Gaunt, Piers

PY - 2016/6/11

Y1 - 2016/6/11

KW - Female

KW - Humans

KW - Incretins

KW - Liraglutide

KW - Male

KW - Non-alcoholic Fatty Liver Disease

U2 - 10.1016/S0140-6736(16)30672-9

DO - 10.1016/S0140-6736(16)30672-9

M3 - Letter

C2 - 27312304

SN - 0140-6736

VL - 387

SP - 2379

JO - The Lancet

JF - The Lancet

IS - 10036

ER -